WHO ICTRP trial
A Multicenter, Randomized, Double-Blind Study of the Co-Administration of…
EUCTR2008-003640-11-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-003640-11-IT |
|---|---|
| Public title | A Multicenter, Randomized, Double-Blind Study of the Co-Administration of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control. - ND |
| Scientific title | A Multicenter, Randomized, Double-Blind Study of the Co-Administration of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control. - ND |
| Primary sponsor | MERCK & CO., INC. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Slovenia;Bulgaria;Estonia;Italy;Greece;Latvia;Austria;Lithuania |
| Conditions | Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control. MedDRA version: 9.1 Level: LLT Classification code 10049746 Term: Insulin-requiring type II diabetes mellitus |
| Interventions | Product Name: sitagliptin/pioglitazone Product Code: MK0431C Pharmaceutical Form: Tablet Current Sponsor code: MK0431C Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- Pharmaceutical form of the… |
| Registration date | Nov 7, 2008 |
| Target size | 1295 |
| Secondary IDs | MK0431C-102 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: